CrkI adapter protein modulates cell migration and invasion in glioblastoma

被引:0
|
作者
Takino, T
Nakada, M
Miyamori, H
Yamashita, J
Yamada, KM
Sato, H
机构
[1] Kanazawa Univ, Canc Res Inst, Dept Mol Virol & Oncol, Grad Sch Med Sci, Kanazawa, Ishikawa 9200934, Japan
[2] Kanazawa Univ, Div Neurosci, Dept Neurosurg, Grad Sch Med Sci, Kanazawa, Ishikawa 9200934, Japan
[3] Natl Inst Dental & Cranofacial Res, Cranoifacial Dev Biol & Regenerat Branch, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The human crk gene is translated into crkI and crkII by alternative splicing. crkII mRNA was detected both in normal brain and glioblastoma tissues, whereas crkI mRNA levels were quite low in normal brain and up-regulated in glioblastoma tissues. Expression of CrkI but not CrkII in glioblastoma U87MG cells induced transformation that stimulated cell migration and invasion concomitant with tyrosine phosphorylation of p130 Crk-associated substrate. N-cadherin-mediated signal transduction, which was essential for invasion by U87MG cells, was no longer required for CrkI-transformed cells. These results suggest that CrkI contributes to malignancy of glioblastoma by inducing phosphorylation of p130 Crk-associated substrate.
引用
收藏
页码:2335 / 2337
页数:3
相关论文
共 50 条
  • [41] Tyrosine phosphorylation of the CrkII adaptor protein modulates cell migration
    Takino, T
    Tamura, M
    Miyamori, H
    Araki, M
    Matsumoto, K
    Sato, H
    Yamada, KM
    JOURNAL OF CELL SCIENCE, 2003, 116 (15) : 3145 - 3155
  • [42] Immune Cell-Type Specific Ablation of Adapter Protein ADAP Differentially Modulates EAE
    Rudolph, Jochen
    Meinke, Clara
    Voss, Martin
    Guttek, Karina
    Kliche, Stefanie
    Reinhold, Dirk
    Schraven, Burkhart
    Reinhold, Annegret
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [43] MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression
    Li, Weihua
    Wu, Chunming
    Yao, Yiqun
    Dong, Bin
    Wei, Zhenqing
    Lv, Xiupeng
    Zhang, Jian
    Xu, Yinghui
    NEUROSCIENCE LETTERS, 2014, 566 : 82 - 87
  • [44] Myristoylated alanine rich protein kinase C substrate is a potential cancer prognostic factor that regulates cell migration and invasion in glioblastoma
    Xiang, Wei
    Peng, Tao
    Ming, Yang
    Li, Shenjie
    Wang, Ke
    Wang, Haorun
    Chen, Ligang
    Zhou, Jie
    ONCOLOGY REPORTS, 2019, 41 (04) : 2464 - 2470
  • [45] Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion
    Zhou, Xiuping
    Liu, Zhi
    Shi, Qiong
    Jiao, Jiantong
    Bian, Wenbin
    Song, Xu
    Mo, Jianbing
    Sang, Ben
    Xu, Yinfu
    Qian, Jinming
    Chao, Yuewen
    Yu, Rutong
    JOURNAL OF NEURO-ONCOLOGY, 2013, 112 (03) : 365 - 374
  • [46] A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion
    Lo, Hui-Wen
    Zhu, Hu
    Cao, Xinyu
    Aldrich, Amy
    Ali-Osman, Francis
    CANCER RESEARCH, 2009, 69 (17) : 6790 - 6798
  • [47] Silencing of Eps8 blocks migration and invasion in human glioblastoma cell lines
    Cattaneo, Maria Grazia
    Cappellini, Elisa
    Vicentini, Lucia M.
    EXPERIMENTAL CELL RESEARCH, 2012, 318 (15) : 1901 - 1912
  • [48] The effect of type III collagen on migration and invasion of human glioblastoma cell lines in vitro
    Chintala, SK
    Sawaya, R
    Gokaslan, ZL
    Rao, JS
    CANCER LETTERS, 1996, 102 (1-2) : 57 - 63
  • [49] Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion
    Xiuping Zhou
    Zhi Liu
    Qiong Shi
    Jiantong Jiao
    Wenbin Bian
    Xu Song
    Jianbing Mo
    Ben sang
    Yinfu Xu
    Jinming Qian
    Yuewen Chao
    Rutong Yu
    Journal of Neuro-Oncology, 2013, 112 : 365 - 374
  • [50] Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines
    Jung, Tae-Young
    Jung, Shin
    Ryu, Hyang-Hwa
    Jeong, Young-Il
    Jin, Yong-Hao
    Jin, Shu-Guang
    Kim, In-Young
    Kang, Sam-Suk
    Kim, Hyung-Seok
    JOURNAL OF NEUROSURGERY, 2008, 109 (02) : 273 - 284